Has baricitinib been included in medical insurance? How much does it cost?

Baricitinib (Baricitinib) is an oral drug that belongs to the class of Januskinase inhibitors (JAK inhibitors). It acts on Janus kinase in the body, inhibiting its activity, thereby interfering with inflammatory responses and immune system signaling. Baricitinib is mainly used to treat rheumatoid arthritis (Rheumatoid Arthritis, RA), rheumatoid arthritis (Psoriatic Autoimmune diseases such as Arthritis, PsA) and psoriatic arthritis (Psoriatic Arthritis, PsA).

Baricitinib has been launched in China and is included in medical insurance. Patients can purchase it domestically. Due to different medical insurance reimbursement policies in different regions, the reimbursement ratio is also different. The price is about 1200~1600 yuan. For specific prices, please consult the local pharmacy or the medical insurance bureau. Baricitinib has both original and generic drugs abroad. The original drug is mainly Eli Lilly’s original drug, and its price is higher than in China. Generic drugs are mainly Bangladeshi generic drugs, and the price is around 450 yuan. The ingredients of original drugs and generic drugs are basically the same.

Baricitinib's mechanism of action is by inhibiting Januskinases, specifically JAK1 and JAK2, which are involved in inflammatory responses and signaling in the immune system. By inhibiting the activity of these kinases, baricitinib can reduce the inflammatory response and immune system activity, thereby reducing the release of inflammatory mediators and related inflammatory cell activity.

Baricitinib is usually taken by mouth once daily, with dosage varying based on individual circumstances and disease. Patients taking baricitinib should take the drug on time according to the instructions of their doctor and follow the medication instructions in the drug package insert.